| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
1 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
-0.0084 |
1 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
0.019 |
1 |